Osteopontin promotes rat hepatocyte proliferation both and .

This study aimed to examine the effects of osteopontin (OPN) on hepatocyte growth and liver regeneration (LR). A recombinant lentivirus expressing OPN and OPN-siRNAs were used to treat BRL-3A cells, while the adenovirus expressing OPN or OPN-targeted shRNA were applied for rat primary hepatocytes. Moreover, rrOPN and OPN-Ab were added to treat BRL-3A. Next, rrOPN was administrated into rat regenerating livers. Then and assays were performed to evaluate the biological function of OPN in hepatocyte growth and LR. OPN overexpression facilitated proliferation and viability of BRL-3A cells and primary hepatocytes, while OPN silencing reversed these effects. Similarly, rrOPN stimulated cell cycle progression and viability, but OPN-Ab led to cell cycle arrest and decreased viability. OPN overexpression induced the expression of p-STAT3, p-AKT and CCND1, and OPN siRNA led to reduction of p-AKT and CCND1. Furthermore, rrOPN promoted the expression of p-STAT3 and p-AKT, while OPN-Ab and PI3K/Akt inhibitor LY294002 both inhibited the expressions of p-AKT and Bcl2. Moreover, LR rate, serum IL-6 and TNF-α, Ki-67 proportion and the phosphorylation of STAT3, AKT and p65 were augmented by rrOPN treatment. OPN promotes hepatocyte proliferation both and through STAT3 and AKT signaling pathways.